Emilien Jeannot1, Philippe Sudre, Philippe Chastonay. 1. Faculty of Medicine, Institute of Social and Preventive Medicine, University of Geneva, Geneva, Switzerland. emilien.jeannot@unige.ch
Abstract
OBJECTIVE: The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during a state-coordinated HPV vaccination program in Geneva, Switzerland, from September 2008 to June 2011. METHODS: State Medical Office coordinated the HPV vaccination program. Each service provider transmitted the list of the persons who had received their first, second, or third shot. RESULTS: The global coverage rates, 3 years after the program had been launched, were 63.72% for one dose, 63.22% for two doses, and 61.40% for three doses of the HPV vaccine. CONCLUSION: This study shows that it is possible to obtain a good coverage rates after 3 years of a state-coordinated HPV vaccination program.
OBJECTIVE: The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during a state-coordinated HPV vaccination program in Geneva, Switzerland, from September 2008 to June 2011. METHODS: State Medical Office coordinated the HPV vaccination program. Each service provider transmitted the list of the persons who had received their first, second, or third shot. RESULTS: The global coverage rates, 3 years after the program had been launched, were 63.72% for one dose, 63.22% for two doses, and 61.40% for three doses of the HPV vaccine. CONCLUSION: This study shows that it is possible to obtain a good coverage rates after 3 years of a state-coordinated HPV vaccination program.
Authors: Charlene A Wong; Zahava Berkowitz; Christina G Dorell; Rebecca Anhang Price; Jennifer Lee; Mona Saraiya Journal: Cancer Date: 2011-06-20 Impact factor: 6.860
Authors: Loretta Brabin; Stephen A Roberts; Rebecca Stretch; David Baxter; Gloria Chambers; Henry Kitchener; Rosemary McCann Journal: BMJ Date: 2008-04-24
Authors: Leah M Smith; Paul Brassard; Jeffrey C Kwong; Shelley L Deeks; Anne K Ellis; Linda E Lévesque Journal: BMC Public Health Date: 2011-08-13 Impact factor: 3.295
Authors: Mona Amadane; Charlotte de Pree; Manuela Viviano; Pierre Vassilakos; Emilien Jeannot; Patrick Petignat Journal: Arch Public Health Date: 2019-06-18
Authors: Shannon E MacDonald; Margaret L Russell; Xianfang C Liu; Kimberley A Simmonds; Diane L Lorenzetti; Heather Sharpe; Jill Svenson; Lawrence W Svenson Journal: Hum Vaccin Immunother Date: 2018-12-20 Impact factor: 3.452